Inosine pranobex in the treatment of viral dermatoses in children


A.S. Botkina, M.I. Dubrovskaya, O.O. Khandamirovan

Pirogov Russian National Research Medical University, Moscow, Russia
Many viral agents causing lesions of the skin and mucous membranes persist for a long time in the human body, causing secondary immunosuppression. Inosine pranobex with simultaneously immunomodulatory and antiviral activity, contributing to the active elimination of the virus from the body, is effective both in the treatment and prevention of various viral dermatoses. Numerous clinical studies, as well as the experience of the use of the drug in more than 70 countries around the world, indicate the efficacy and safety of inosine pranobex for the treatment of patients with confirmed viral infections.

About the Autors

Corresponding author: Aleksandra S. Botkina, Cand. Sci. (Med.), Associate Professor at the Department of Hospital Pediatrics n.a. Acad. V.A. Tabolin, Faculty of Pediatrics, Pirogov Russian National Research Medical University, Russia;

Similar Articles

Бионика Медиа